Dr. Reddy's launches generic LIPITOR tablets in the U.S.

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched ATORVASTATIN CALCIUM TABLETS 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of LIPITOR® (atorvastatin calcium) tablets, in the US market on July 17, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for atorvastatin calcium tablets.

The LIPITOR® brand had U.S. sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr. Reddy's Atorvastatin Calcium Tablets in 10 mg, 20 mg, 40 mg and 80 mg are available in bottle count sizes of 90 and 500.


Dr. Reddy's Laboratories


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Novel drug candidate offers a major advance in the treatment for diabetes